Parameter
| Biomarker | IL - 6, sCD163 | Full name | Interleukin-6, soluble CD163 | Molecular Type | Protein (cytokines/macrophage marker) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Inflammation monitoring and disease progression assessment | ||
| Disease | Chronic pancreatitis (CP) | Disease Subtypes | / | ||
| Organ | Pancreas | Test Sample / Technology Platform | Serum (ELISA, immunoassay) | ||
| Pathobiological Mechanisms | IL - 6 mediated chronic inflammation, reflect sCD163 macrophage activation, the participation of the CP process of chronic inflammation, fibrosis | ||||
| Clinical Availability Status | Clinical study phase: persistently elevated in CP patients and associated with disease progression | ||||
| Notes and Dynamics | It can be used to monitor the inflammatory activity of CP and evaluate the control effect of treatment on inflammation. It is expected to be included in the clinical monitoring system | ||||